ARHGEF9 and Global developmental delay: Severe ID is prevalent among patients with ARHGEF9 mutation (46.3%), and all patients bear some extent of ID (and/or developmental delay (DD) in infants; Fig. 1a, b and Supplementary Tables 2, 3).